Adolescents and adults are affected differently by vaping and have different health concerns, according to Ilona Jaspers, PhD, director of toxicology and the deputy director of the Center for Environmental Medicine, Asthma, and Lung Biology at the Gillings School of Global Public Health at the University of North Carolina.
Adolescents and adults are affected differently by vaping and have different health concerns, according to Ilona Jaspers, PhD, director of toxicology and the deputy director of the Center for Environmental Medicine, Asthma, and Lung Biology at the Gillings School of Global Public Health at the University of North Carolina. She is also a professor of pediatrics, microbiology, and immunology.
Transcript:
How are adolescents impacted by vaping differently than adults, and why does this occur?
So, I think it is because the lungs are not fully developed in teenagers. And so, are there any developmental concerns that could unfold later in life? That's certainly one thing. One aspect that we are currently really interested in is that about 18 months ago, all research, even the vaping research, had a shift towards COVID-19. Everyone is doing COVID-19. Everyone in the respiratory field is doing something related to COVID-19. And 1 concern for us was that there are epidemiological studies indicating that those who vape e-cigarettes, either alone or together with conventional cigarettes, are more likely to get COVID-19 and may have, other disease outcomes. So, we're still actively investigating that.
But another aspect that's hitting us, potentially right now, is does vaping potentially affect the ability and longevity of COVID-19 vaccine antibodies? And that is obviously of importance to teenagers and young adults because probably, once they get the vaccine, they think it's basically back to 2019 and are behaving accordingly. But are their behaviors or their their use of e-cigarettes and vaping actually modify potentially their immunity, either acutely or long term? That is something that we're actively investigating now.
The Pivotal Role of Payers in Improving Health Equity, Maternal Health Care in the US
March 26th 2024A presentation at the Greater Philadelphia Business Coalition on Health's 2024 Women’s Health Summit discussed how payers, including employers and public entities, can strategically influence health care purchasing to prioritize maternal health and equity.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Dr Al Benson on Reimbursement for Supportive Care When Treating Patients With Cancer
March 22nd 2024Al Benson, MD, FACP, FACCC, FASCO, medical oncologist at Northwestern University Feinberg School of Medicine and associate director of the Robert E. Tillery Comprehensive Cancer Center, discussed findings from a national survey assessing barriers to comprehensive cancer care delivery.
Read More
Dupilumab Considered Safe, Effective Treatment for Adolescent, Adult Patients With AD
March 20th 2024These posters both used the GLOBOSTAD study, which demonstrated through patient and physician assessments that dupilumab is a safe and effective treatment for adolescent and adult patients with atopic dermatitis (AD).
Read More